文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The role of hydroxyurea in sickle cell disease.

作者信息

Halsey Christina, Roberts Irene A

机构信息

Department of Haematology, Great Ormond Street Hospital for Sick Children, London, UK.

出版信息

Br J Haematol. 2003 Jan;120(2):177-86. doi: 10.1046/j.1365-2141.2003.03849.x.

DOI:10.1046/j.1365-2141.2003.03849.x
PMID:12542474
Abstract
摘要

相似文献

[1]
The role of hydroxyurea in sickle cell disease.

Br J Haematol. 2003-1

[2]
Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.

Blood Cells Mol Dis. 2000-10

[3]
Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.

Am J Hematol. 2015-7

[4]
Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.

Int J Mol Sci. 2018-2-28

[5]
Hydroxurea and sickle cell disease: Its been a long, long time coming.

Pediatr Blood Cancer. 2010-2

[6]
Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.

Haematologica. 2015-10

[7]
Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.

Blood Adv. 2018-11-30

[8]
Hydroxyurea therapy in children severely affected with sickle cell disease.

J Pediatr. 1996-6

[9]
Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.

Lancet Glob Health. 2015-3

[10]
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Medicine (Baltimore). 1996-11

引用本文的文献

[1]
Consensus of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) and the Brazilian Ministry of Health - General management of blood and blood products on the tests necessary for the release of exceptional medicines for sickle cell disease.

Hematol Transfus Cell Ther. 2024

[2]
A Critical Review of Sickle Cell Disease Burden and Challenges in Sub-Saharan Africa.

J Blood Med. 2023-5-31

[3]
Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria.

PLoS One. 2022

[4]
Pediatric hematology providers' contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey.

Pediatr Blood Cancer. 2022-10

[5]
Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria.

Afr Health Sci. 2021-6

[6]
Perception to hydroxyurea therapy in patients with sickle cell disease: Report from 3 centers.

Ann Afr Med. 2021

[7]
Smartphone-based sickle cell disease detection and monitoring for point-of-care settings.

Biosens Bioelectron. 2020-10-1

[8]
Current Issues and Options for Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease: An Update for Health Care Professionals.

Mediterr J Hematol Infect Dis. 2020-5-1

[9]
Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.

J Trop Pediatr. 2020-6-1

[10]
Associations of transcranial doppler velocity, age, and gender with cognitive function in children with sickle cell anemia in Nigeria.

Child Neuropsychol. 2018-10-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索